Skip to main content

Rising Bilateral Trade Costs to Impact Australian OTC Market

By 20 Aug, 2014November 18th, 2019Insights, Regulations
 This article was originally published in Bloomberg Brief’s inaugural Financial Regulation Asia-Pacific Region Special on Aug. 1, 2014.
GreySpark’s Shekar Says Rising Bilateral Trade Costs to Impact Australian OTC Market
Malavika Shekar, consultant at GreySpark Partners in Australia, says the rising cost of trading and funding margin on bilateral trades, the shift in liquidity from the bilateral to the cleared markets and the advent of electronic platform trading are three factors that will impact Australian buy-side firms in the over-the-counter derivatives market as regulators take steps to make local requirements stronger.

This content is restricted to site members. If you are an existing user, please log in. New users may register below.


Login

Register